1 |
An update on immunotherapy with PD-1 and PD-L1 blockade
Sung Ae Koh
Yeungnam Univ J Med.2021;38(4):308-317. Published online 2021 September 9
DOI: http://dx.doi.org/10.12701/yujm.2021.01312
|
|
2 |
Characterization and Prognostic Significance of Cutaneous Adverse Events to Anti-Programmed Cell Death-1 Therapy
Ye Jin Lee, Hak Tae Kim, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Jee Ho Choi, Woo Jin Lee
J Korean Med Sci.2019;34(26):e186. Published online 2019 June 17
DOI: http://dx.doi.org/10.3346/jkms.2019.34.e186
|
|
3 |
Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization
Hyeyoon Chang, Jin Hwa Hong, Jae-Kwan Lee, Hyun Woong Cho, Yung Taek Ouh, Kyung Jin Min, Kyeong A So
J Gynecol Oncol.2018;29(3):e27. Published online 2018 January 29
DOI: http://dx.doi.org/10.3802/jgo.2018.29.e27
|
|